Molnupiravir, developed by Merck with partner Ridgeback Biotherapeutics, is intended to be used at home to treat Covid in people 18 and older at risk of developing severe illness 

from mint - Science https://ift.tt/3yRjIUN
https://ift.tt/eA8V8J

Post a Comment

Previous Post Next Post